Shanghai Titan Scientific Co., Ltd. (SHSE:688133) agreed to acquire 26.6667% stake in RADOBIO Scientific Co., Ltd. on March 21, 2024. As of December 31, 2023, RADOBIO Scientific Co., Ltd. generated total assets of CNY10.87 million, net assets of CNY 1.9 million, revenue of CNY 22.87 million and net loss of CNY 5.7 million. The transaction is approved by board of directors of Shanghai Titan Scientific Co., Ltd. and is subject to approval by shareholders of Shanghai Titan Scientific Co., Ltd.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
26.37 CNY | +0.19% | -2.77% | -43.11% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-43.11% | 428M | |
+15.30% | 65.31B | |
+0.37% | 49.06B | |
+20.81% | 42.92B | |
+26.72% | 27.27B | |
+8.74% | 19.24B | |
+9.44% | 16.57B | |
-2.61% | 16.53B | |
-14.33% | 14.55B | |
-30.36% | 14.09B |
- Stock Market
- Equities
- 688133 Stock
- News Shanghai Titan Scientific Co., Ltd.
- Shanghai Titan Scientific Co., Ltd. agreed to acquire 26.6667% stake in RADOBIO Scientific Co., Ltd.